NCT07146347View on ClinicalTrials.gov

Comparison Study of Insulin GZR4 With Insulin Degludec

PHASE1RecruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

June 1, 2026

Conditions
Type 2 Diabetes
Interventions
DRUG

GZR4 injection

GZR4 is a new ultra-long-acting insulin analog

Trial Locations (1)

Unknown

RECRUITING

Profil, Neuss

Sponsors
All Listed Sponsors
collaborator

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

lead

Gan and Lee Pharmaceuticals, USA

INDUSTRY

NCT07146347 - Comparison Study of Insulin GZR4 With Insulin Degludec | Biotech Hunter | Biotech Hunter